Rationale and use of near-infrared spectroscopy for detection of lipid-rich and vulnerable plaques

Journal of Nuclear Cardiology

Volumn 14, Issue 5, 2007, Pages 719-728

  Waxman, Sergio ^a,b   Ishibashi, Fumiyuki ^a,b   Caplan, Jay D ^c  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b INFRAREDX INC   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; AUTOPSY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE; DIAGNOSTIC ACCURACY; DRUG ELUTING STENT; EX VIVO STUDY; HEART CATHETERIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; NEAR INFRARED SPECTROSCOPY; NON INVASIVE PROCEDURE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SAFETY; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

CORONARY ARTERIOSCLEROSIS; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; LIPIDS; SPECTROPHOTOMETRY, INFRARED;

EID: 34548426426     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.08.001     Document Type: Article

References (53)

1. Encrenaz T. Solar-system studies in the infrared range recent developments and future plans. Infrared Phys Technol 35 (1994) 95-106
2. Ciurczak E.W., and Drennen III J.K. Pharmaceutical and medical applications of near-infrared spectroscopy (2002), Marcel Dekker, New York
3. Gabriely I., Wozniak R., Mevorach M., Kaplan J., Aharon Y., and Shamoon H. Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. Diabetes Care 22 (1999) 2026-2032
4. Mendelson Y. Pulse oximetry: theory and applications for noninvasive monitoring. Clin Chem 38 (1992) 1601-1607
5. Cassis L.A., and Lodder R.A. Near-IR imaging of atheromas in living arterial tissue. Anal Chem 65 (1993) 1247-1256
6. Dempsey R.J., Cassis L.A., Davis D.G., and Lodder R.A. Near-infrared imaging and spectroscopy in stroke research: lipoprotein distribution and disease. Ann N Y Acad Sci 820 (1997) 149-169
7. Jaross W., Neumeister V., Lattke P., and Schuh D. Determination of cholesterol in atherosclerotic plaques using near infrared diffuse reflection spectroscopy. Atherosclerosis 147 (1999) 327-337
8. Neumeister V., Scheibe M., Lattke P., and Jaross W. Determination of the cholesterol-collagen ratio of arterial atherosclerotic plaques using near infrared spectroscopy as a possible measure of plaque stability. Atherosclerosis 165 (2002) 251-257
9. Wang J., Geng Y.J., Guo B., Klima T., Lal B.N., Willerson J.T., et al. Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques. J Am Coll Cardiol 39 (2002) 1305-1313
10. Moreno P.R., Lodder R.A., Purushothaman K.R., Charash W.E., O'Connor W.N., and Muller J.E. Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation 105 (2002) 923-927
11. Moreno P.R., and Muller J.E. Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods. Curr Opin Cardiol 17 (2002) 638-647
12. Moreno P.R., and Muller J.E. Detection of high-risk atherosclerotic coronary plaques by intravascular spectroscopy. J Interv Cardiol 16 (2003) 243-252
13. Caplan J.D., Waxman S., Nesto R.W., and Muller J.E. Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques. J Am Coll Cardiol 47 (2006) C92-C96
14. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull W., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92 (1995) 1355-1374
15. Stary H.C. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 20 (2000) 1177-1178
16. Davies M.J. The pathophysiology of acute coronary syndromes. Heart 83 (2000) 361-366
17. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
18. Muller J.E., Abela G.S., Nesto R.W., and Tofler G.H. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 23 (1994) 809-813
19. Fuster V., Moreno P.R., Fayad Z.A., Corti R., and Badimon J.J. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 46 (2005) 937-954
20. Vink A., and Pasterkamp G. Atherosclerotic plaques: how vulnerable is the definition of "the vulnerable plaque"?. J Interv Cardiol 16 (2003) 115-122
21. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
22. Libby P., and Theroux P. Pathophysiology of coronary artery disease. Circulation 111 (2005) 3481-3488
23. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 47 (2006) C7-C12
24. van der Wal A.C., Becker A.E., van der Loos C.M., and Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994) 36-44
25. Farb A., Burke A.P., Tang A.L., Liang T.Y., Mannan P., Smialek J., et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 93 (1996) 1354-1363
26. Virmani R., Kolodgie F.D., Burke A.P., Farb A., and Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20 (2000) 1262-1275
27. Kolodgie F.D., Burke A.P., Farb A., Gold H.K., Yuan J., Narula J., et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 16 (2001) 285-292
28. Virmani R., Burke A.P., Kolodgie F.D., and Farb A. Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol 16 (2003) 267-272
29. Virmani R., Burke A.P., Farb A., and Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 47 (2006) C13-C18
30. Schaar J.A., Muller J.E., Falk E., Virmani R., Fuster V., Serruys P.W., et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 25 (2004) 1077-1082
31. Waxman S., Ishibashi F., and Muller J.E. Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events. Circulation 114 (2006) 2390-2411
32. Fuster V., Fayad Z.A., Moreno P.R., Poon M., Corti R., and Badimon J.J. Atherothrombosis and high-risk plaque: part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol 46 (2005) 1209-1218
33. Libby P. Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques. J Am Coll Cardiol 45 (2005) 1600-1602
34. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 50 (1983) 127-134
35. Frink R.J. Chronic ulcerated plaques: new insights into the pathogenesis of acute coronary disease. J Invasive Cardiol 6 (1994) 173-185
36. Hong M.K., Mintz G.S., Lee C.W., Kim Y.H., Lee S.W., Song J.M., et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 110 (2004) 928-933
37. Goldstein J.A., Chandra H.R., and O'Neill W.W. Relation of number of complex coronary lesions to serum C-reactive protein levels and major adverse cardiovascular events at one year. Am J Cardiol 96 (2005) 56-60
38. Wang J.C., Normand S.L., Mauri L., and Kuntz R.E. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 110 (2004) 278-284
39. Cutlip D.E., Chhabra A.G., Baim D.S., Chauhan M.S., Marulkar S., Massaro J., et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation 110 (2004) 1226-1230
40. Nogueira G.V., Silveira L., Martin A.A., Zangaro R.A., Pacheco M.T., Chavantes M.C., et al. Raman spectroscopy study of atherosclerosis in human carotid artery. J Biomed Opt 10 (2005) 031117
41. Motz J.T., Puppels G.J., Waxman S., Bakker Schut T.C., Marple E., Green N., et al. Percutaneous intracoronary Raman spectroscopy. [abstract]. Cardiovasc Revasc Med 8 (2007) 127
42. Roberts W.C. Diffuse extent of coronary atherosclerosis in fatal coronary artery disease. Am J Cardiol 65 (1990) 2F-6F
43. Small D.M. George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry. Arteriosclerosis 8 (1988) 103-129
44. Marshik B., Tan H., Tang J., et al. Discrimination of lipid-rich plaques in human aorta specimens with NIR spectroscopy through whole blood. [abstract]. Am J Cardiol 90 Suppl 6A (2002) 129H
45. Marshik B., Tan H., Tang J., et al. Detection of thin-capped fibroatheromas in human aorta tissue with near infrared spectroscopy through blood. [abstract]. J Am Coll Cardiol 41 Suppl 1 (2003) 42
46. Waxman S., Tang J., Marshik B.J., Tan H., Khabbaz K.R., Connolly R.J., et al. In vivo detection of a coronary artificial target with a near infrared spectroscopy catheter. [abstract]. Am J Cardiol 94 Suppl 6A (2004) 141E
47. Waxman S., Khabbaz K., Connolly R., Tang J., Dabreo A., Egerhei L., et al. Intravascular imaging of atherosclerotic human coronaries in a porcine model: a feasibility study. Int J Cardiovasc Imaging (2007) In press
48. Waxman S., L'Allier P., Tardif J.C., Goldstein J., Ishibashi F., Caplan J.D., et al. Scanning near-infrared (NIR) spectroscopy of coronary arteries for detection of lipid-rich plaque in patients undergoing PCI-early results of the SPECTACL study. [abstract]. Circulation 114 (2006) II-647
49. Waxman S, L'Allier P, Goldstein J, Krucoff MW, Tardif JC, Dixon S, et al. Detection of lipid rich plaque by near infrared spectroscopy (NIRS) in patients undergoing coronary intervention: results in an unblinded cohort of the SPECTroscopic assessment of coronary lipid (SPECTACLE) study. Am J Cardiol. In press.
50. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
51. Oyabu J., Ueda Y., Ogasawara N., Okada K., Hirayama A., and Kodama K. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J 152 (2006) 1168-1174
52. Garcia-Garcia H.M., Goedhart D., and Serruys P.W. Relation of plaque size to necrotic core in the three major coronary arteries in patients with acute coronary syndrome as determined by intravascular ultrasonic imaging radiofrequency. Am J Cardiol 99 (2007) 790-792
53. Nicholls S.J., Tuzcu E.M., Sipahi I., Grasso A.W., Schoenhagen P., Hu T., et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 297 (2007) 499-508